BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Moleculin Biotech (NASDAQ:MBRX)

1 post

Biotech NewsThe “No Heart Damage” Cancer Drug Angle: Is Moleculin (MBRX)’s Annamycin the Plot Twist in AML?

  • BioTech Health X
  • February 12, 2026
We recently published our article Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026. This piece…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • The “No Heart Damage” Cancer Drug Angle: Is Moleculin (MBRX)’s Annamycin the Plot Twist in AML?
  • Achieve Life Sciences (ACHV) Has a June 2026 “Make-or-Break” Date—Is This the Smoking Cessation Biotech Everyone’s Early On?
  • Avalo Therapeutics (AVTX)’s Next 5 Minutes of Fame: The HS Data Drop That Could Shock Traders
  • DBV Technologies (DBVT) Didn’t Chase a Fad — It Built a Category: The Peanut Allergy Patch
  • MindMed (MNMD) Stock 101: Why This Psychedelic Biotech Isn’t Playing Small Anymore
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • February 12, 2026
    The “No Heart Damage” Cancer Drug Angle: Is Moleculin (MBRX)’s Annamycin the Plot Twist in AML?
    • February 12, 2026
    Achieve Life Sciences (ACHV) Has a June 2026 “Make-or-Break” Date—Is This the Smoking Cessation Biotech Everyone’s Early On?
    • February 12, 2026
    Avalo Therapeutics (AVTX)’s Next 5 Minutes of Fame: The HS Data Drop That Could Shock Traders
    • February 12, 2026
    DBV Technologies (DBVT) Didn’t Chase a Fad — It Built a Category: The Peanut Allergy Patch
    • February 12, 2026
    MindMed (MNMD) Stock 101: Why This Psychedelic Biotech Isn’t Playing Small Anymore
Recent Posts
  • Top 5 Best Biotech Micro-Caps With Major Clinical Catalysts in 2026
    • February 12, 2026
  • ADMA Biologics (ADMA): #1 Biotech Stock Pick for February 2026
    • February 8, 2026
  • Here’s What Makes Biohaven (BHVN) a Smart Long-Term Buy
    • February 8, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (776)
  • Uncategorized (2)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top